Source: European Medicines Agency (EU) Revision Year: 2025 Publisher: SERB S.A., Avenue Louise 480, 1050 Brussels, Belgium
Cyanokit 5 g powder for solution for infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for infusion. Dark red crystalline powder. |
Each vial contains 5 g of hydroxocobalamin.
After reconstitution with 200 mL of diluent, each mL of the reconstituted solution contains 25 mg of hydroxocobalamin.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
The action of hydroxocobalamin in the treatment of cyanide poisoning is based on its ability to tightly bind cyanide ions. Each hydroxocobalamin molecule can bind one cyanide ion by substituting the hydroxo ligand linked to the trivalent cobalt ion to form cyanocobalamin. Cyanocobalamin is a stable, non-toxic compound that is excreted in the urine. |
| List of Excipients |
|---|
|
Hydrochloric acid (for pH-adjustment) |
Type I colourless 250 mL glass vial closed with bromobutyl rubber stopper and an aluminium cap with a plastic lid.
Each pack contains one vial packed in one cardboard box, one sterile transfer device, one sterile intravenous infusion set and one sterile short catheter for administration to children.
SERB S.A., Avenue Louise 480, 1050 Brussels, Belgium
EU/1/07/420/002
Date of first authorisation: 23 November 2007
Date of latest renewal: 20 July 2012
| Drug | Countries | |
|---|---|---|
| CYANOKIT | Austria, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Japan, Lithuania, Netherlands, Poland, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.